BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15908656)

  • 1. Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point.
    Guillem JG; Chessin DB; Shia J; Moore HG; Mazumdar M; Bernard B; Paty PB; Saltz L; Minsky BD; Weiser MR; Temple LK; Cohen AM; Wong WD
    J Clin Oncol; 2005 May; 23(15):3475-9. PubMed ID: 15908656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
    Lindebjerg J; Spindler KL; Ploen J; Jakobsen A
    Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
    Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation.
    Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Saltz LB; Goodman KA; Minsky BD; Wong WD; Weiser MR
    Cancer; 2008 Jul; 113(1):57-64. PubMed ID: 18442099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging accuracy in assessing tumour down-staging following chemoradiation in rectal cancer.
    Suppiah A; Hunter IA; Cowley J; Garimella V; Cast J; Hartley JE; Monson JR
    Colorectal Dis; 2009 Mar; 11(3):249-53. PubMed ID: 18513192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative chemoradiation therapy for low rectal cancer. Impact on downstaging and sphincter-saving operations.
    Habr-Gama A; Perez RO; Kiss DR; Rawet V; Scanavini A; Santinho PM; Nadalin W
    Hepatogastroenterology; 2004; 51(60):1703-7. PubMed ID: 15532809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline polymorphisms may act as predictors of response to preoperative chemoradiation in locally advanced T3 rectal tumors.
    Spindler KL; Nielsen JN; Lindebjerg J; Jakobsen A
    Dis Colon Rectum; 2007 Sep; 50(9):1363-9. PubMed ID: 17661145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The correlation between tumour regression grade and lymph node status after chemoradiation in rectal cancer.
    Berho M; Oviedo M; Stone E; Chen C; Nogueras J; Weiss E; Sands D; Wexner S
    Colorectal Dis; 2009 Mar; 11(3):254-8. PubMed ID: 18513188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET/CT and histopathologic response to preoperative chemoradiation therapy in locally advanced rectal cancer.
    Kristiansen C; Loft A; Berthelsen AK; Graff J; Lindebjerg J; Bisgaard C; Jakobsen A
    Dis Colon Rectum; 2008 Jan; 51(1):21-5. PubMed ID: 17975715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
    Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG
    Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted.
    Guillem JG; Díaz-González JA; Minsky BD; Valentini V; Jeong SY; Rodriguez-Bigas MA; Coco C; Leon R; Hernandez-Lizoain JL; Aristu JJ; Riedel ER; Nitti D; Wong WD; Pucciarelli S
    J Clin Oncol; 2008 Jan; 26(3):368-73. PubMed ID: 18202411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative chemotherapy and radiotherapy for locally advanced rectal cancer.
    Chao M; Gibbs P; Tjandra J; Cullinan M; McLaughlin S; Faragher I; Skinner I; Jones I
    ANZ J Surg; 2005 May; 75(5):286-91. PubMed ID: 15932438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
    Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL
    Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer.
    Vecchio FM; Valentini V; Minsky BD; Padula GD; Venkatraman ES; Balducci M; Miccichè F; Ricci R; Morganti AG; Gambacorta MA; Maurizi F; Coco C
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):752-60. PubMed ID: 15936556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squamous-cell carcinoma of the rectum: a rare but curable tumor.
    Nahas CS; Shia J; Joseph R; Schrag D; Minsky BD; Weiser MR; Guillem JG; Paty PB; Klimstra DS; Tang LH; Wong WD; Temple LK
    Dis Colon Rectum; 2007 Sep; 50(9):1393-400. PubMed ID: 17661147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete clinical response after preoperative chemoradiation in rectal cancer: is a "wait and see" policy justified?
    Glynne-Jones R; Wallace M; Livingstone JI; Meyrick-Thomas J
    Dis Colon Rectum; 2008 Jan; 51(1):10-9; discussion 19-20. PubMed ID: 18043968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy: implications for sphincter preservation.
    Guillem JG; Chessin DB; Shia J; Suriawinata A; Riedel E; Moore HG; Minsky BD; Wong WD
    Ann Surg; 2007 Jan; 245(1):88-93. PubMed ID: 17197970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation.
    Díaz-González JA; Calvo FA; Cortés J; García-Sabrido JL; Gómez-Espí M; Del Valle E; Muñoz-Jiménez F; Alvarez E
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1122-8. PubMed ID: 16406393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer.
    Das P; Skibber JM; Rodriguez-Bigas MA; Feig BW; Chang GJ; Hoff PM; Eng C; Wolff RA; Janjan NA; Delclos ME; Krishnan S; Levy LB; Ellis LM; Crane CH
    Am J Clin Oncol; 2006 Jun; 29(3):219-24. PubMed ID: 16755173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.